Unraveling severe sepsis - Why did OPTIMIST fail and what's next?

被引：27

作者：

Angus, DC

Crowther, MA

机构：

[1] Univ Pittsburgh, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness Lab, Pittsburgh, PA 15261 USA

[2] McMaster Univ, Dept Med, Hamilton, ON, Canada

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2003年 / 290卷 / 02期

关键词：

D O I：

10.1001/jama.290.2.256

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：256 / 258

页数：3

共 35 条

[31] Novel strategies for the treatment of sepsis
Riedemann, NC
Guo, RF
Ward, PA
[J]. NATURE MEDICINE, 2003, 9 (05) : 517 - 524
[32] Early goal-directed therapy in the treatment of severe sepsis and septic shock.
Rivers, E
Nguyen, B
Havstad, S
Ressler, J
Muzzin, A
Knoblich, B
Peterson, E
Tomlanovich, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) : 1368 - 1377
[33] Intensive insulin therapy in critically ill patients.
Van den Berghe, G
Wouters, P
Weekers, F
Verwaest, C
Bruyninckx, F
Schetz, M
Vlasselaers, D
Ferdinande, P
Lauwers, P
Bouillon, R
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) : 1359 - 1367
[34] High-dose a randomized antithrombin III in severe sepsis -: A randomized controlled trial
Warren, BL
Eid, A
Singer, P
Pillay, SS
Carl, P
Novak, I
Chalupa, P
Atherstone, A
Pénzes, I
Kübler, A
Knaub, S
Keinecke, HO
Heinrichs, H
Schindel, F
Juers, M
Bone, RC
Opal, SM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (15): : 1869 - 1878
[35] Risks and benefits of activated protein C treatment for severe sepsis.
Warren, HS
Suffredini, AF
Eichacker, PQ
Munford, RS
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) : 1027 - 1030